The expiration of bedaquiline's patent could potentially increase its availability worldwide. Once a drug's patent expires, generic versions can be produced, leading to increased competition and potentially lower prices. This could make the drug more accessible to patients in need, particularly in low- and middle-income countries where affordability is a significant barrier to accessing essential medications like bedaquiline [1][2][3]. Additionally, the availability of generic versions could lead to greater distribution and availability of the drug in regions where it is currently scarce, ultimately benefiting more individuals in the fight against tuberculosis [2][3]. However, the actual impact of the patent expiration on bedaquiline's availability will depend on various factors, including regulatory approvals, manufacturing capacity, and market dynamics [1].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/BEDAQUILINE
[2] https://time.com/6295511/how-an-innovative-deal-will-give-millions-access-to-cheaper-tuberculosis-drugs/
[3] https://abcnews.go.com/Health/millions-access-life-saving-tuberculosis-drug-online-uproar/story?id=101483658